Issuance of Guidelines on the Provision of Sales Information and GDP
First written in FY2019. 1 of 2 entries say "Restated". Latest entry: FY2020.
No other company in this theme has enough history to compare yet.
- FY2020RestatedAnnual report
「In 2018, the Guidelines for Distribution Stakeholders to Follow to Improve the Distribution of Prescription Pharmaceuticals, the Guidelines on Activities to Provide Sales Information for Prescription Pharmaceuticals, and the Guidelines for Good Distribution Practices (GDP) for Pharmaceuticals were issued,」
The company reconfirmed the new operating standards, including the guidelines on sales information provision and GDP, as changes in the business environment. - FY2019First statedAnnual report
「In September 2018, the Ministry of Health, Labour and Welfare issued the Guidelines on Activities to Provide Sales Information for Prescription Pharmaceuticals, aimed at ensuring the proper use of prescription pharmaceuticals by regulating advertising and advertising-like activities conducted by marketing authorization holders and others in connection with sales information provision. In December 2018, it issued the Guidelines for Good Distribution Practices (GDP) for Pharmaceuticals, aimed at ensuring appropriate management of pharmaceutical distribution channels.」
The issuance in September and December 2018 of new Ministry of Health, Labour and Welfare guidelines covering sales information provision for prescription pharmaceuticals and good distribution practices was first described as a change in the business environment.